Apolipoprotein E modulates abcg2 transporter expression and function in the context of teriflunomide-therapy of experimental autoimmune encephalomyelitis

2016 | conference abstract. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Apolipoprotein E modulates abcg2 transporter expression and function in the context of teriflunomide-therapy of experimental autoimmune encephalomyelitis​
Schrewe, L.; Meyer, D.; Boehme, A.; Pittlik, S. M.; Demir, S.; Faissner, S. & Hagemann, N. et al.​ (2016)
Multiple Sclerosis Journal, 22 pp. 165​-166. ​32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)​, London, ENGLAND.
London​: Sage Publications Ltd.

Copy

Further links

Documents & Media

License

GRO License GRO License

Details

Authors
Schrewe, L.; Meyer, D.; Boehme, A.; Pittlik, S. M.; Demir, Seray; Faissner, S.; Hagemann, N.; Schmidt, D.; Hermann, Dirk M.; Luehder, Fred; Chan, A.
Issue Date
2016
Status
published
Publisher
Sage Publications Ltd
Journal
Multiple Sclerosis Journal 
Conference
32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)
Conference Place
London, ENGLAND
ISSN
1477-0970; 1352-4585
Sponsor
Genzyme; Novartis; Biogen; Teva; Bayer; Merck; Roche; Teva Neuroscience

Export Metadata

Refman EndNote BibTeX RefWorks Excel CSV

Reference

Citations